Enhancement of the IFN-β-induced host signature informs repurposed drugs for COVID-19

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a causative agent for the outbreak of coronavirus disease 2019 (COVID-19). This global pandemic is now calling for efforts to develop more effective COVID-19 therapies. Here we use a host-directed approach, which focuses on cellular res...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Heliyon
Hauptverfasser: Huang, Chen-Tsung, Chao, Tai-Ling, Kao, Han-Chieh, Pang, Yu-Hao, Lee, Wen-Hau, Hsieh, Chiao-Hui, Chang, Sui-Yuan, Huang, Hsuan-Cheng, Juan, Hsueh-Fen
Format: Artigo
Sprache:Inglês
Veröffentlicht: Elsevier 2020
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7709728/
https://ncbi.nlm.nih.gov/pubmed/33289002
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.heliyon.2020.e05646
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge